DIMENSIONAL FUND ADVISORS LP - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 62 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$209
-100.0%
231,417
-16.2%
0.00%
-100.0%
Q3 2022$1,658,000
+69.4%
276,266
+16.8%
0.00%
Q2 2022$979,000
+17.2%
236,535
+7.6%
0.00%
Q1 2022$835,000
-8.4%
219,864
+8.5%
0.00%
Q4 2021$912,000
-15.9%
202,684
-12.9%
0.00%
Q3 2021$1,085,000
-13.5%
232,763
+30.8%
0.00%
Q2 2021$1,255,000
+306.1%
177,998
+240.6%
0.00%
Q1 2021$309,00052,2530.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 20,711$81,0000.89%
RA Capital Management 4,681,858$18,212,0000.33%
Ghost Tree Capital, LLC 200,000$778,0000.22%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$7,336,0000.13%
Virtu Financial LLC 39,062$152,0000.03%
Quantitative Systematic Strategies LLC 14,195$55,0000.01%
Cetera Advisor Networks LLC 85,000$331,0000.01%
BAILARD, INC. 38,600$150,0000.01%
Chicago Partners Investment Group LLC 14,081$52,0000.01%
EXANE DERIVATIVES 4,078$15,863,0000.01%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders